Comments on EFSA's opinion about the health claim "improvement of bowel function" for hydroxyanthracenic derivatives

Phytomedicine. 2014 Jun 15;21(7):928-30. doi: 10.1016/j.phymed.2014.02.015. Epub 2014 Apr 2.
No abstract available

Publication types

  • Letter

MeSH terms

  • Age Factors
  • Constipation / diet therapy*
  • Dietary Supplements
  • European Union
  • Female
  • Food-Drug Interactions
  • Humans
  • Laxatives / adverse effects
  • Laxatives / therapeutic use
  • Legislation, Drug / organization & administration
  • Legislation, Food* / organization & administration
  • Plants, Medicinal / adverse effects*
  • Pregnancy

Substances

  • Laxatives